サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1489204

フェニレフリン薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Phenylephrine Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 177 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
フェニレフリン薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年05月01日
発行: Value Market Research
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フェニレフリン薬の世界需要は、2023年の220億5,000万米ドルから2032年には406億1,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは7.02%です。

フェニレフリン薬は、風邪、アレルギー、副鼻腔炎などの症状に関連する鼻づまりや副鼻腔圧を緩和するために使用される薬剤のクラス別です。鼻腔の血管を収縮させ、腫れや鼻づまりを軽減し、呼吸を楽にします。これらの薬剤は、点鼻薬、経口錠剤、点眼薬など様々な製剤があり、投与方法や投与量に柔軟性があります。一般に、指示通りに使用すれば安全で効果的であると考えられているが、これらの薬剤は、個人によっては血圧上昇、心拍の速さ、頭痛を引き起こすことがあります。市販の風邪薬やアレルギー薬によく含まれており、鼻づまりや関連症状を緩和します。

市場力学

鼻づまり、副鼻腔炎、アレルギー性鼻炎の世界の有病率の増加と、風邪、インフルエンザ、呼吸器感染症の罹患率の上昇が、市販薬や処方薬としてのフェニレフリン系鼻づまり除去薬の需要を牽引しています。鼻づまりや関連症状の緩和を求める人々が多い中、フェニレフリン系薬剤は鼻腔の血管を狭め、腫れや鼻づまりを軽減することで、迅速かつ効果的な緩和を提供します。さらに、ドラッグ製剤、デリバリーシステム、併用療法の進歩がフェニレフリン薬の技術革新を促進し、多様な患者のニーズを満たすための徐放性製剤、複数の症状を緩和する製剤、小児に適した剤形の開発を可能にしています。

さらに、フェニレフリン薬の点眼薬、経口薬、心血管サポートのための注射剤への用途拡大が、市場の成長と多様化を促進しています。さらに、セルフケア、ウェルネス、予防医療への注目の高まりは、消費者が家庭で風邪やアレルギーの症状を管理するための便利で利用しやすい解決策を求めるため、市販のフェニレフリン製品に対する需要を促進しています。しかし、代替の充血除去薬の利用可能性や鼻づまりの非薬理学的治療の出現は、今後数年間の市場成長の課題となる可能性があります。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはフェニレフリン薬の世界市場における各セグメントを包括的に評価することもできます。フェニレフリン薬産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるフェニレフリン薬市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 フェニレフリン薬の産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 フェニレフリン薬の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • 錠剤
  • シロップ剤
  • 点眼薬
  • その他

第6章 フェニレフリン薬の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口
  • 非経口
  • その他

第7章 フェニレフリン薬の世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • 風邪
  • 鼻の充血除去
  • アレルギー反応
  • 眼疾患
  • その他

第8章 フェニレフリン薬の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • ドラッグストア・小売薬局
  • オンライン薬局

第9章 フェニレフリン薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 フェニレフリン薬企業の競合情勢

  • フェニレフリン薬の市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Novartis AG
  • Perrigo Company PLC
  • Johnson & Johnson Consumer Inc.（Kenvue Inc.）
  • Proctor & Gamble Co.
  • Pfizer Inc.
  • Foundation Consumer Brands LLC
  • Mylan N.V.
  • Torrent Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrups Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Nasal Decongestion Market Sales By Geography (USD MN)
  • Allergic Reaction Market Sales By Geography (USD MN)
  • Eye Disease Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores & Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Phenylephrine Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Phenylephrine Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Phenylephrine Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Syrups Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Cold Market Sales By Geography (USD MN)
  • Nasal Decongestion Market Sales By Geography (USD MN)
  • Allergic Reaction Market Sales By Geography (USD MN)
  • Eye Disease Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores & Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114533

The global demand for Phenylephrine Drugs Market is presumed to reach the market size of nearly USD 40.61 Billion by 2032 from USD 22.05 Billion in 2023 with a CAGR of 7.02% under the study period 2024-2032.

Phenylephrine drugs are a class of medications employed to alleviate nasal congestion and sinus pressure linked with conditions like the common cold, allergies, and sinusitis. They constrict blood vessels in the nasal passages, reducing swelling and congestion and facilitating easier breathing. These drugs are available in various formulations, including nasal sprays, oral tablets, and eye drops, providing flexibility in administration and dosage. Though generally regarded as safe and effective when used according to instructions, these drugs may cause elevated blood pressure, rapid heartbeat, and headache in some individuals. They are commonly found in over-the-counter cold and allergy medications, relieving nasal congestion and related symptoms.

MARKET DYNAMICS

The increasing prevalence of nasal congestion, sinusitis, and allergic rhinitis worldwide, coupled with the rising incidence of colds, flu, and respiratory infections, drives demand for phenylephrine-based decongestants as over-the-counter and prescription medications. As individuals seek relief from nasal congestion and related symptoms, phenylephrine drugs offer rapid and effective relief by narrowing nasal passages blood vessels and reducing swelling and congestion. Additionally, advancements in drug formulations, delivery systems, and combination therapies drive innovation in phenylephrine drugs, enabling the development of extended-release formulations, multi-symptom relief products, and pediatric-friendly dosage forms to meet diverse patient needs.

Furthermore, the expanding applications of phenylephrine drugs in ophthalmic solutions, oral medications, and injectable formulations for cardiovascular support are driving market growth and diversification. Moreover, the increasing focus on self-care, wellness, and preventive healthcare drives demand for over-the-counter phenylephrine products as consumers seek convenient and accessible solutions for managing cold and allergy symptoms at home. However, the availability of alternative decongestant medications and the emergence of non-pharmacological treatments for nasal congestion may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Phenylephrine Drugs. The growth and trends of Phenylephrine Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Phenylephrine Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Tablets
  • Syrups
  • Eye Drops
  • Other

By Route Of Administration

  • Oral
  • Parenteral
  • Other

By Indication

  • Cold
  • Nasal Decongestion
  • Allergic Reaction
  • Eye Disease
  • Other

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Phenylephrine Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Phenylephrine Drugs market include Novartis AG, Perrigo Company PLC, Johnson & Johnson Consumer Inc. (Kenvue Inc.), Proctor & Gamble Co., Pfizer Inc., Foundation Consumer Brands LLC, Mylan N.V., Torrent Pharmaceuticals Inc., GlaxoSmithKline PLC, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PHENYLEPHRINE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Tablets Historic and Forecast Sales By Regions
  • 5.5. Syrups Historic and Forecast Sales By Regions
  • 5.6. Eye Drops Historic and Forecast Sales By Regions
  • 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route Of Administration
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Route Of Administration
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. Parenteral Historic and Forecast Sales By Regions
  • 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Indication
  • 7.4. Cold Historic and Forecast Sales By Regions
  • 7.5. Nasal Decongestion Historic and Forecast Sales By Regions
  • 7.6. Allergic Reaction Historic and Forecast Sales By Regions
  • 7.7. Eye Disease Historic and Forecast Sales By Regions
  • 7.8. Other Historic and Forecast Sales By Regions

8. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Drug Stores & Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PHENYLEPHRINE DRUGS COMPANIES

  • 10.1. Phenylephrine Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PHENYLEPHRINE DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Perrigo Company PLC
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Johnson & Johnson Consumer Inc. (Kenvue Inc.)
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Proctor & Gamble Co.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Pfizer Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Foundation Consumer Brands LLC
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Mylan N.V.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Torrent Pharmaceuticals Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. GlaxoSmithKline PLC
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Bayer AG
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies